Clinical trials
Tuberculosis trials with no applicable phase and unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 4 |
| 2018 | 6 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 5 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 55 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liverpool School of Tropical Medicine | 3 |
| Taipei Medical University WanFang Hospital | 3 |
| University of Cape Town | 3 |
| Beijing Chest Hospital | 2 |
| Mbarara University of Science and Technology | 2 |
| National Taiwan University Hospital | 2 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 2 |
| Shanghai Public Health Clinical Center | 2 |
| Tuberculosis Clinical Diagnostics Research Consortium | 2 |
| University of Stellenbosch | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberculosis | 55 |
| Tuberculosis, Pulmonary | 7 |
| Lung Neoplasms | 5 |
| Sarcoidosis | 5 |
| Acquired Immunodeficiency Syndrome | 3 |
| Disease | 3 |
| Lymphoma | 3 |
| Bronchiectasis | 2 |
| HIV Infections | 2 |
| Hemoptysis | 2 |
Trials
Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.